» Articles » PMID: 15316518

Clinical Features and Severity Grading of Anaphylaxis

Overview
Date 2004 Aug 19
PMID 15316518
Citations 229
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Existing grading systems for acute systemic hypersensitivity reactions vary considerably, have a number of deficiencies, and lack a consistent definition of anaphylaxis.

Objective: The aims of this study were to develop a simple grading system and definition of anaphylaxis and to identify predictors of reaction severity.

Methods: Case records from 1149 systemic hypersensitivity reactions presenting to an emergency department were analyzed retrospectively. Logistic regression analyses of the associations between individual reaction features and hypotension and hypoxia were used to construct a grading system. Epinephrine use, etiology, age, sex, comorbidities, and concurrent medications were then assessed for their association with reaction grade.

Results: Confusion, collapse, unconsciousness, and incontinence were strongly associated with hypotension and hypoxia and were used to define severe reactions. Diaphoresis, vomiting, presyncope, dyspnea, stridor, wheeze, chest/throat tightness, nausea, vomiting, and abdominal pain had weaker, albeit significant, associations and were used to define moderate reactions. Reactions limited to the skin (urticaria, erythema, and angioedema) were defined as mild. These grades correlated well with epinephrine usage. Older age, insect venom, and iatrogenic causes were independent predictors of severity. Preexisting lung disease was associated with an increased risk of hypoxia.

Conclusion: This simple grading system has potential value for defining reaction severity in clinical practice and research settings. The moderate and severe grades provide a workable definition of anaphylaxis. Age, reaction precipitant, and preexisting lung disease appear to be the major determinants of reaction severity.

Citing Articles

Evaluation of drug-related anaphylaxis in children: multi-center study.

Metbulut A, Haci I, Can D, Bekis Bozkurt H, Cavkaytar O, Arga M Eur J Pediatr. 2025; 184(3):230.

PMID: 40053151 DOI: 10.1007/s00431-025-06068-x.


Desensitization to colecalciferol in 18 patients with immediate hypersensitivity reactions.

Atik O, Tepetam F, Ozden S, Can A, Saylan B World Allergy Organ J. 2025; 18(2):101029.

PMID: 40034581 PMC: 11873155. DOI: 10.1016/j.waojou.2025.101029.


Case report: Tocilizumab for hypersensitivity reaction after oxaliplatin in a patient with NK/T-cell lymphoma.

Liao J, Jiang M Front Pharmacol. 2025; 15:1471038.

PMID: 39881879 PMC: 11775475. DOI: 10.3389/fphar.2024.1471038.


The increasing role of the allergist in the management of infusion reactions at the Oncology Infusion Center.

Borras Cuartero J, Torres Gorriz M, Stein Coronado C, German Sanchez A, Pesantez Mendez C, Latorre Ibanez M Front Allergy. 2024; 5:1479469.

PMID: 39723347 PMC: 11668695. DOI: 10.3389/falgy.2024.1479469.


Anaphylaxis.

Abrams E, Alqurashi W, Fischer D, Vander Leek T, Ellis A Allergy Asthma Clin Immunol. 2024; 20(Suppl 3):62.

PMID: 39654057 PMC: 11629490. DOI: 10.1186/s13223-024-00926-3.